Skip to content

Randomised trial, 2001

Does hormone replacement therapy change serotonin receptors in postmenopausal women?

No significant change was found in serotonin transporter or 5-HT2A receptor binding with hormone treatment in healthy postmenopausal women, though depressed women showed a more pronounced effect.

Moderate study design 23 postmenopausal women with climacteric symptoms

What they did

Researchers studied 23 postmenopausal women in a double-blind randomised crossover study. Each woman received 2 mg estradiol continuously during 28-day cycles. In the last 14 days of each cycle, she received either 10 mg medroxyprogesterone, 1 mg norethindrone, or placebo. Blood samples were taken before treatment and during the last week of each treatment to measure serotonin receptor binding.

What they found

There was no change in serotonin transporter binding or 5-HT2A receptor binding with any hormone treatment in the overall group. However, in women who were depressed, the decrease in 5-HT2A receptor binding during treatment was significantly more pronounced than in non-depressed women (P less than .05).

What it means for you

Hormone replacement therapy does not change serotonin receptors in healthy postmenopausal women, but may work differently in depressed women. This is a laboratory measurement of receptor binding, not a study of whether hormone therapy helps mood symptoms. Main limit: this only studied postmenopausal women, not women of reproductive age with PMS.

23

postmenopausal women

2 mg

daily estradiol dose

P<.05

significance in depressed subgroup

About the study

Original title
Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding
Authors
Wihlbäck AC, Sundström-Poromaa I, Allard P et al.
Journal
Obstetrics and gynecology
Year
2001
Study design
Randomised trial
What was tested
Estradiol 2 mg daily plus medroxyprogesterone, norethindrone, or placebo

Topics